clinical trials retatrutide parkinson's trial Retatrutide, an experimental drug currently in Phase 3 clinical trials, is nicknamed A new weight-loss drug called
Description
We dont have much data yet and the Phase I so far was mixed, with Phase II data coming this year
Dao K, Shechtman S, Diav-Citrin O, et al
This raises the potential for H3R inverse agonism/antagonism to influence food intake via transmitters other than histamine ( Figure 3 )
Therefore, the activation of the IGF-2/IGF-1R axis may contribute to -cell survival in response to GLP-1, and importantly, the increased IGF-2 secretion may be essential for triggering this response, as also observed in embryonic development (41)
